According to Transpire Insight, the global head lice infestation drug market is undergoing a structural shift driven by rising drug resistance to legacy over-the-counter (OTC) treatments, higher adoption of non-neurotoxic formulations, and integrated digital healthcare access. As head lice populations develop widespread resistance to traditional neurotoxic insecticides,...